Risk Assessment and Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography

被引：3
作者：
Okumura, Kenji [1 ]
Sone, Takahito [1 ]
机构：
[1] Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Japan
来源：
INTERNAL MEDICINE | 2012年 / 51卷 / 06期
关键词：
contrast-induced nephropathy; ascorbic acid; coronary angiography; risk assessment and prevention; ATRIAL-NATRIURETIC-PEPTIDE; ACUTE-RENAL-FAILURE; ASCORBIC-ACID; INTERVENTION; METAANALYSIS; DYSFUNCTION; MEDIA; INSUFFICIENCY; MORTALITY; OUTCOMES;
D O I：
10.2169/internalmedicine.51.6875
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：519 / 521
页数：3
相关论文
共 50 条
[31]   Risk Factors for Hemodialysis and Mortality in Patients With Contrast-Induced Nephropathy [J].
Lai, Hoang M. ;
Aronow, Wilbert S. ;
Chugh, Savneek S. ;
Pudasaini, Basudev ;
Goel, Arvind ;
Garrick, Renee .
AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (06) :607-612
[32]   Prevention of Contrast-induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Elective Coronary Angioplasty or Angiography with Sodium Potassium Citrate Solution, a Double Blind Randomized Clinical Trial [J].
Ghorbani, Ali ;
Yazdankhah, Saeed ;
Adel, Mohamad-Hasan ;
Tabesh, Hamed ;
Sattari, Alireza ;
Sattari, Shahab-aldin ;
Heybar, Habib ;
Madjidi, Shahla .
IRANIAN JOURNAL OF KIDNEY DISEASES, 2019, 13 (03) :182-190
[33]   Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography [J].
Elserafy, Ahmed Shawky ;
Okasha, Nireen ;
Hegazy, Tamim .
EGYPTIAN HEART JOURNAL, 2018, 70 (02) :107-111
[34]   Atorvastatin and prevention of contrast induced nephropathy following coronary angiography [J].
Bidram, Peyman ;
Roghani, Farshad ;
Sanei, Hamid ;
Hedayati, Zahraparin ;
Golabchi, Allahyar ;
Mousavi, Mehdi ;
Hajiannejad, Alireza ;
Pourheidar, Behrouz ;
Badalabadi, Mehdi Mohseni ;
Gharaati, Maryam ;
Akhbari, Mohammadreza ;
Salesi, Asieh .
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2015, 20 (01) :1-6
[35]   Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention [J].
Li, Wen-Hua ;
Li, Dong-Ye ;
Qian, Wen-Hao ;
Liu, Jia-Li ;
Xu, Tong-Da ;
Zhu, Hong ;
He, Hai-Yan .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (04) :781-786
[36]   Sodium Bicarbonate-Ascorbic Acid Combination for Prevention of Contrast-Induced Nephropathy in Chronic Kidney Disease Patients Undergoing Catheterization [J].
Komiyama, Kota ;
Ashikaga, Takashi ;
Inagaki, Dai ;
Miyabe, Tomonori ;
Arai, Marina ;
Yoshida, Kiyotaka ;
Miyazawa, Satoshi ;
Nakada, Akihiro ;
Kawamura, Iwanari ;
Masuda, Shinichiro ;
Nagamine, Sho ;
Hojo, Rintaro ;
Aoyama, Yuya ;
Tsuchiyama, Takaaki ;
Fukamizu, Seiji ;
Shibui, Takashi ;
Sakurada, Harumizu .
CIRCULATION JOURNAL, 2017, 81 (02) :235-240
[37]   Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: Risk-factors and prognostic value [J].
Zaytseva, Natalia V. ;
Shamkhalova, Minara S. ;
Shestakova, Marina V. ;
Matskeplishvili, Simon T. ;
Tugeeva, Elvina F. ;
Buziashvili, Ury I. ;
Deev, Alexandr D. ;
Dedov, Ivan I. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 86 :S63-S69
[38]   Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization [J].
Capodanno, Davide ;
Ministeri, Margherita ;
Dipasqua, Fabio ;
Dalessandro, Veronica ;
Cumbo, Silvia ;
Gargiulo, Giuseppe ;
Tamburino, Corrado .
JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (07) :524-529
[39]   The Prevention of Contrast-Induced Nephropathy [J].
Au, Trang H. ;
Bruckner, Anne ;
Mohiuddin, Syed M. ;
Hilleman, Daniel E. .
ANNALS OF PHARMACOTHERAPY, 2014, 48 (10) :1332-1342
[40]   Association Between Remnant Cholesterol and Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and/or Percutaneous Coronary Intervention [J].
Luo, Baolin ;
Huang, Xizhen ;
Peng, Yanchun ;
Luo, Hanbin ;
Chen, Liangwan ;
Lin, Yanjuan .
ANGIOLOGY, 2025, 76 (05) :466-475
12345